Skip to main content
Swing Capital

Torrent Pharmaceuticals Ltd

NSE: TORNTPHARM BSE: 500420Pharma

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

₹4,394
52W: ₹3102 — ₹4556
PE 66.6 · Book ₹250 · +1658% vs book
Market Cap₹1,48,725 Cr
Stock P/E66.6Price to Earnings
ROCE27.8%Return on Capital
ROE26.2%Return on Equity
Div. Yield0.73%Face Value ₹5

Strengths

  • +Company has reduced debt.
  • +Company has been maintaining a healthy dividend payout of 50.5%

Weaknesses

  • −Stock is trading at 17.4 times its book value
  • −The company has delivered a poor sales growth of 9.44% over past five years.

Shareholding Pattern

Promoters68.31%
FIIs16.18%
DIIs8.96%
Public6.55%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters71.25%71.25%68.31%▼2.968.31%68.31%68.31%68.31%68.31%
FIIs14.22%14.46%▲0.216.17%▲1.716.31%▲0.116.09%▼0.215.92%▼0.216.13%▲0.216.18%▲0.1
DIIs7.17%6.98%▼0.28.25%▲1.38.25%8.54%▲0.39.17%▲0.69.05%▼0.18.96%▼0.1
Public7.25%7.21%▼0.07.17%▼0.07.02%▼0.26.93%▼0.16.47%▼0.56.41%▼0.16.55%▲0.1

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales2,1462,1232,1432,4382,4342,3772,4332,6162,7622,599
Expenses1,4101,4221,4271,5391,5131,4901,5651,6371,6901,599
Operating Profit7367017168999218878689791,0721,000
OPM %34%33%33%37%38%37%36%37%39%38%
Net Profit327297410469460485474551597577
EPS ₹9.668.7812.1113.8613.5914.3314.0116.2817.6417.05

AI Insights

Revenue Trend

TTM revenue at ₹10,410Cr, up 7.5% YoY. OPM at 38%.

Debt Position

Borrowings at ₹2,115Cr. Debt-to-equity ratio: 0.26x. Healthy balance sheet.

Capex Cycle

CWIP at ₹485Cr (7% of fixed assets). Moderate ongoing capital expenditure.

Institutional Flow

DIIs: 8.96% (+0.74pp change). FIIs: 16.18% (+3.33pp change). Promoters hold 68.31%.

Margin & Efficiency

ROCE declining from 35% (Mar 2014) to 28% (Mar 2025). Working capital days: 43.

Valuation

PE 66.6x with 27.8% ROCE. Price is 1658% above book value of ₹250. Dividend yield: 0.73%.

Recent Announcements